Drug
Leo 90100 Foam
Leo 90100 Foam: highest development phase Phase 3, developed by LEO Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 90100 foam NCT03806790 | Phase 3 | Psoriasis Vulgaris |
| LEO 90100 foam NCT03476746 | Phase 1 | Healthy |
Latest
No recent events.
Follow Leo 90100 Foam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.